MeSH D004942 - peptic esophagitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Famotidine | Famotidine |  | 2001-12-17 |  |  |
| Ajanta Pharma | Ranitidine | Ranitidine |  | 2018-09-27 |  |  |
| Famotidine | Famotidine |  | 2023-09-18 |  |  | |
| Akorn | Famotidine | Famotidine |  | 2014-05-30 |  |  |
| Alembic Pharmaceuticals | Famotidine | Famotidine |  | 2009-05-22 |  |  |
| Alkem Laboratories | Famotidine, Ibuprofen | Ibuprofen Famotidine |  | 2021-08-03 |  |  |
| Famotidine | Famotidine |  | 2022-01-07 |  |  | |
| Allergan | Famotidine | Famotidine |  | 2001-04-16 |  |  |
| Nizatidine | Nizatidine |  | 2002-07-09 |  |  | |
| Ranitidine | Ranitidine |  | 1997-10-20 |  |  | |
| Amneal Pharmaceuticals | Famotidine | Famotidine |  | 2022-08-04 |  |  |
| Nizatidine | Nizatidine |  | 2009-11-18 |  |  | |
| Ranitidine | Ranitidine |  | 2006-10-13 | $8.678 M | Y2017 | |
| ANI Pharmaceuticals | Nizatidine | Nizatidine |  | 2002-07-08 |  |  |
| Ranitidine | Ranitidine |  | 1997-07-31 |  |  | |
| Annora Pharma | Famotidine | Famotidine |  | 2021-11-08 |  |  |
| Apotex | Famotidine | Famotidine |  | 2002-03-12 |  |  |
| Nizatidine | Nizatidine |  | 2003-01-23 |  |  | |
| Ranitidine | Ranitidine |  | 1997-09-12 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
86%6/7
Phase 3
85%11/13
Approved: 6Overall Success rate: 36%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use